NeuMoDx Molecular, Inc. clinical trials
Acquired by QIAGEN, Sep 17, 2020 · source ↗
The registry lists 1 studies whose lead sponsor is NeuMoDx Molecular, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 12, 2020.
Before and after it joined QIAGEN
- First submitted before NeuMoDx Molecular, Inc. became part of QIAGEN
- 1
- First submitted after NeuMoDx Molecular, Inc. became part of QIAGEN
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- NeuMoDx Molecular, Inc.1 study
Something wrong with this grouping? Tell us on the QIAGEN page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All QIAGEN studies →
- NeuMoDx PrEDiCTiNG Study Evaluation PlanCompletedNCT03970850Not applicable
Sponsor listed in the registry: NeuMoDx Molecular, Inc. · First submitted before NeuMoDx Molecular, Inc. became part of QIAGEN